Literature DB >> 15129401

Walking ability and its relationship to lower-extremity muscle strength in children with idiopathic inflammatory myopathies.

Karen Lohmann Siegel1, Jeanne E Hicks, Deloris E Koziol, Lynn H Gerber, Lisa G Rider.   

Abstract

OBJECTIVE: To describe gait deficits and their association with lower-extremity muscle strength in children with juvenile idiopathic inflammatory myopathies (IIM).
DESIGN: Cross-sectional, descriptive study.
SETTING: Clinical research center. PARTICIPANTS: Consecutive sample of 25 ambulatory children diagnosed with juvenile IIM.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Manual muscle test (MMT) of bilateral hip flexor, extensor, and abductor; knee extensor; and ankle plantarflexor strength, all measured on a 0- to 10-point scale and summary strength measures. Video-based movement analysis to determine walking speed; gait cycle time; right and left step time; stride length; right and left step length; and stance, swing, and double-limb support phase durations.
RESULTS: Walking speed (1.03+/-0.27 m/s) was reduced because of shortened stride lengths (1.03+/-0.21 m) more than prolonged gait cycle times (1.05+/-0.22s). Walking speed highly correlated with the number of muscle groups weaker than grade 7 out of 10 (r=-.89) and the strength of the hip flexors (r=.85).
CONCLUSIONS: Lower-extremity strength measures, including MMT scores of individual muscle groups and the number of weak muscle groups, were predictive of gait limitations in children with juvenile IIM.

Entities:  

Mesh:

Year:  2004        PMID: 15129401     DOI: 10.1016/j.apmr.2003.07.005

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

Review 1.  Recent advances in juvenile dermatomyositis.

Authors:  Ann M Reed; Thomas Mason
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

2.  A case study of gait compensations for hip muscle weakness in idiopathic inflammatory myopathy.

Authors:  Karen Lohmann Siegel; Thomas M Kepple; Steven J Stanhope
Journal:  Clin Biomech (Bristol, Avon)       Date:  2006-12-21       Impact factor: 2.063

3.  Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.

Authors:  Lisa G Rider; Adrienne L Yip; Iren Horkayne-Szakaly; Rita Volochayev; Joseph A Shrader; Maria L Turner; Heidi H Kong; Minal S Jain; Anna V Jansen; Chester V Oddis; Thomas A Fleisher; Frederick W Miller
Journal:  Clin Exp Rheumatol       Date:  2014-07-28       Impact factor: 4.473

4.  Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis.

Authors:  M O Harris-Love; J A Shrader; D Koziol; N Pahlajani; M Jain; M Smith; H L Cintas; C L McGarvey; L James-Newton; A Pokrovnichka; B Moini; I Cabalar; D J Lovell; R Wesley; P H Plotz; F W Miller; J E Hicks; L G Rider
Journal:  Rheumatology (Oxford)       Date:  2008-12-11       Impact factor: 7.580

5.  Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer.

Authors:  Barbara A Springer; Ellen Levy; Charles McGarvey; Lucinda A Pfalzer; Nicole L Stout; Lynn H Gerber; Peter W Soballe; Jerome Danoff
Journal:  Breast Cancer Res Treat       Date:  2010-02       Impact factor: 4.872

6.  Physical function, muscle strength and muscle mass in children on peritoneal dialysis.

Authors:  Gamze Alayli; Ozan Ozkaya; Kenan Bek; Altan Calmaşur; Bariş Diren; Yüksel Bek; Ferhan Cantürk
Journal:  Pediatr Nephrol       Date:  2008-01-16       Impact factor: 3.714

7.  Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series.

Authors:  Todd Levine
Journal:  Drug Des Devel Ther       Date:  2012-06-11       Impact factor: 4.162

8.  Hand-Held Dynamometry Isometric Torque Reference Values for Children and Adolescents.

Authors:  Luc J Hébert; Désirée B Maltais; Céline Lepage; Joanne Saulnier; Mélanie Crête
Journal:  Pediatr Phys Ther       Date:  2015       Impact factor: 3.049

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.